Infection of cagA-positive Helicobacter pylori (H. pylori) is associated with severe gastritis, peptic ulcer disease, and gastric carcinoma (Kuipers et al., 1995a, b; Blaser et al., 1995; Kuipers 1997) . Epidemiological studies have further indicated that cagA-positive H. pylori is present in the gastric mucosa of most, if not all, patients with gastric mucosa-associated lymphoid tissue (MALT) lymphoma (Eck et al., 1997) . Furthermore, mice infected with cagA-positive H. pylori develop severe gastritis and atrophic changes in their stomach (Sheu et al., 1999) , followed by the development of MALT lymphoma (Wang et al., 2000) . Together with the clinical observations that eradication of H. pylori by antibiotic therapy can lead to complete remission of MALT lymphoma (Wotherspoon et al., 1993) , these observations provide evidence that cagA-positive H. pylori plays an important role in the development and/or maintenance of MALT lymphoma.
Much attention has been focused on the role of the cagA gene product, CagA, in malignant transformation of cells. CagA is directly injected from the bacteria into the attached gastric epithelial cells (Odenbreit et al., 2000) and undergoes tyrosine phosphorylation (Selbach et al., 2002; Stein et al., 2002) . In gastric epithelial cells, the phosphorylated CagA specifically binds to intracellular targets, including SHP-2 tyrosine phosphatase and C-terminal Src kinase (Csk), in a tyrosine phosphorylation-dependent manner (Higashi et al., 2002; Tsutsumi et al., 2003) . Deregulation of intracellular signal transducers by the injected CagA has been suspected to be involved in the development of gastric pathogenesis, eventually leading to gastric adenocarcinoma.
Normal gastric mucosa does not possess organized lymphoid tissues. H. pylori infection stimulates immune lymphocytes in the gastric mucosa and induces the formation of MALT, from which MALT lymphoma of B-cell origin develops (Du and Isaacson, 2002) . Immune cells constituting MALT migrate to and infiltrate the site of H. pylori infection in the stomach. Furthermore, following extensive destruction of the gastric mucosa by severe gastritis or ulceration, the likelihood that lymphocytes will come into direct contact with cagApositive H. pylori dramatically increases. In such circumstances, CagA may be injected into lymphocytes as well as gastric epithelial cells.
With this notion in mind, we examine the effects of CagA in nongastric epithelial cells, particularly in B cells. To this end, we transfected an expression vectormouse pro-B cell line, BaF/6-1 (Hoshikawa et al., 1998a, b) (Figure 1a ). When transiently expressed in AGS human gastric epithelial cells, both wild-type CagA and the CagADN mutant localized in the plasma membrane, underwent tyrosine phosphorylation, bound to SHP-2, and induced comparable levels of elongated cell morphology known as the hummingbird phenotype ( Figure 1b) . Accordingly, the N-terminal truncation did not destroy the structural integrity of CagA that is required for its biological activity in the gastric cells. After multiple rounds of transfection into BaF/6-1 cells, we isolated two independent clones, DN-1 and DN-2, that stably express CagADN. Despite much effort, however, we were not able to isolate stable transfectants for wild-type CagA. It is possible that overexpression of wild-type CagA in BaF/6-1 cells induced apoptosis as was the case with gastric epithelial cells (Tsutsumi et al., 2003) . Such a CagA activity might have caused a difficulty in establishing stable transfectants. At present, however, we do not have any evidence that wild-type CagA or CagADN provokes apoptosis in BaF/6-1 cells. Also notably, the bacterial cagA gene is extremely rich in A and T and contains multiple ATTTA sequences, that, when transcribed into AUUUA, may destabilize mRNA in mammalian cells (Ross, 1996) . Such an mRNA instability might explain why we failed to establish stable transfectants expressing significant levels of wildtype CagA in the B cells. In this regard, the gene encoding CagADN mutant lacks six out of 15 ATTTA sequences present in the wild-type cagA gene. The CagADN mutant was detected as a 90-kDa band in lysates prepared from DN-1 or DN-2 cells. Immunoblotting with anti-phosphotyrosine revealed that CagADN underwent tyrosine phosphorylation in the lymphoid cells (Figure 1c) .
Employing the CagADN stable transfectants, we first examined the effect of CagA on IL-3-dependent B-cell growth by counting cell number at 24 h intervals. The growth curve revealed that CagADN inhibited the B-cell proliferation (Figure 2a) . To determine the cell-cycle phase influenced by CagA, we starved cells by depriving IL-3 from the culture and arrested them in the G1 phase. At 24 h after the starvation, most of the cells had entered into G1 phase as determined by flow cytometric analysis. The G1-arrested cells were then restimulated with IL-3, and their cell cycle progression was monitored by flow cytometry. As shown in Figure 2b , both of the CagADN transfectants exhibited significant delay in G1-S transition, indicating that CagA acts as a G1 inhibitor in the B cell.
The IL-3 signal is primarily transmitted by the sequential activation of JAK2 and STAT5 (Silvennoinen et al., 1993; Mui et al., 1996; Flores-Morales et al., 1998; Reddy et al., 2000) . Accordingly, we investigated the possibility of interference by CagA with the IL-3-dependent JAK-STAT signaling by examining its effect on STAT5-responsive promoters. To this end, we transfected a luciferase reporter gene that was connected to a c-fos promoter or b-casein promoter (Gouilleux et al., 1994) , and the promoter construct was transfected into the parental BaF/6-1 cells or each of the CagADN transfectants. As demonstrated in Figure 3a and b, the STAT5-responsive promoter activities were greatly reduced in cells expressing CagADN. The same results were also obtained by transiently cotransfecting the luciferase reporter construct together with wild-type CagA or CagADN expression vector in the parental BaF/6-1 cells. The observation indicates that suppression of the JAK-STAT signaling is the biological activity of CagA, not specific to the CagADN mutant. Furthermore, the phosphorylation-resistant CagA mutant, PR-CagA, in which all of the EPIYA motifs were mutated (Higashi et al., 2002) , also inhibited c-fos or b- (Hoshikawa et al., 1998a, b) . Cells were cultured in RPMI 1640 medium containing 10% fetal calf serum (FCS) and 20% WEHI 3B-conditioned medium as a source of IL-3. Stable transfectants were generated by cotransfecting pSP65SRa-WT-CagA or pSP65SRa-CagADN with puromycinresistant gene (pBabe-puro). Transfected cells were selected in medium containing 1.5 mg/ml puromycin and stable clones were established by limiting dilution method. Cell lysates prepared from parental BaF/6-1 or the CagADN transfectant cells (70 mg total protein per lane) were subjected to SDS-polyacrylamide gel electrophoresis (SDS-PAGE). Proteins were then transferred to polyvinylidene difluoride (PVDF) membrane filters (Millipore) and the filter was incubated with primary antibody, anti-HA antibody (Y-11; Santa Cruz) or anti-phosphotyrosine (p-Tyr) antibody (4G10; Upstate), followed by anti-mouse or anti-rabbit secondary antibody conjugated to horseradish peroxidase. Protein bands were visualized using Western Blot Chemiluminescence Reagent (Perkin- (Figure 3a, b) . Thus, the CagA activity on the JAK-STAT pathway is independent of its phosphorylation. We also examined the effect of CagA on another growth-promoting gene, c-myc. As was the case with c-fos, the c-myc promoter was significantly repressed in the CagADN transfectants, and, again, this inhibition was independent of CagA phosphorylation (Figure 3c ). /ml in RPMI 1640 containing 10% FCS without IL-3. After 24 h of IL-3 starvation, cells were restimulated with IL-3 by adding WEHI 3B-conditioned medium at a final concentration of 20% for additional 16 h. Before (top panels) and after IL-3 restimulation (bottom panels), cells were harvested, washed and fixed in 70% ethanol on ice. The cells were resuspended in PBS containing 500 mg/ml RNase A. The cells were then incubated in propidium iodide solution (100 mg/ml propidium iodide, 0.1% sodium citrate) prior to flow cytometric analysis 
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Effects of H. pylori CagA on B cells S Umehara et al A hallmark of cancer cell is the acquisition of resistance to apoptosis. If CagA is involved in the development of MALT lymphoma, then an intriguing possibility is that CagA prevents apoptosis and promotes accumulation of genetically abnormal cells that must otherwise be eliminated from the tissue. To address this possibility, we examined the effect of CagA on the p53 tumor suppressor, an important regulator of apoptosis. Recently, Palacios et al. (2000) have demonstrated that, in IL-3-dependent B cells including BaF3, apoptosis induced by inhibitors of deoxyribonucleotide synthesis such as hydroxyurea is dependent on p53, while cell death induced by DNA-damaging agents such as X-irradiation and cisplatin is p53-independent in this particular cell type. We therefore treated the parental BaF/6-1 cell or the CagADN transfectants with hydroxyurea for 22 h and examined levels of apoptosis. As shown in Figure 4a , sub-G1 cells undergoing apoptosis by hydroxyurea were significantly less in the DN-1 or DN-2 transfectant cells than those in the BaF/6-1 cells.
p53 exerts its biological activity at least partly by regulating gene expression. Accordingly, we next examined the effect of CagA on p53 activity as a transcription factor by transfecting a p53-responsive luciferase reporter plasmid, pRGC-Luc or pMDM2-Luc, into the parental BaF/6-1 cells or the CagADN transfectants (Figure 4b, c; left panels) . The results show that p53-dependent promoter activation was significantly impaired in cells expressing CagADN. Given this, we next cotransfected an expression vector for wild-type CagA or PR-CagA together with pRGC-Luc or pMDM2-Luc into the parental BaF/6-1 cells. Again, in this transient expression system, both wild-type and the phosphorylation-resistant CagA proteins inhibited the p53-dependent promoter activities (Figure 4b , c; right panels). The observations indicate that suppression of the p53 function is the biological activity of CagA, not restricted to CagADN, and suggest that the CagA activity is independent of its tyrosine phosphorylation. Since CagA is a membrane-localized protein and p53 is a nuclear protein, it is unlikely that CagA directly interacts with p53 and inhibits its function. This prompted us to examine the effects of CagA on the levels of p53. As shown in Figure 4d , p53 protein levels in the CagADN transfectants were lower than those in parental BaF/6-1 cells. Upon hydroxyurea treatment, p53 levels increased in the parental BaF/6-1 cells, whereas p53 accumulation was significantly impaired in the CagADN transfectants. To address whether downregulation of p53 by CagA is at the transcriptional level or the posttranscriptional level, we examined the effect of CagA on p53 mRNA by quantitative real-time polymerase chain reaction (PCR) analysis. The results show that, in both untreated and HU-treated cells, p53 mRNA levels were significantly decreased in the CagADN transfectants when compared to the parental BaF/6-1 cells. From these observations, we concluded that CagA inhibited p53 expression at the transcription level and thereby hampered p53 functions in B cells.
We have demonstrated in this work that ectopic expression of CagA in IL-3-dependent B-lymphoid cells suppresses cell proliferation through suppression of the JAK-STAT signaling. We have also shown that CagA counteracts hydroxyurea-induced B-cell apoptosis by inhibiting p53 accumulation. Notably, these CagA activities in B cells were independent of tyrosine phosphorylation of CagA. The findings are in contrast to results of previous studies using gastric epithelial cells showing that CagA exerts morphological transformation upon tyrosine phosphorylation (Higashi et al., 2002; Tsutsumi et al., 2003) . These observations collectively indicate that CagA possesses both phosphorylationdependent and -independent activities and that the biological impacts of CagA depend on cell context.
CagA interferes with IL-3-dependent cell proliferation. Although the mechanisms underlying the growth inhibition remain to be elucidated, CagA impedes the JAK-STAT pathway and hence counteracts activation of STAT-responsive genes. Subsequent inhibition of cmyc activation results in retardation of G1-to S-phase cell-cycle progression (Seoane et al., 2002; Gartel and Shchors, 2003) . Given that the JAK-STAT pathway is not a major pathway of mitogenic signaling in epithelial cells, growth-suppressive activity of CagA is likely to be Santa Cruz) . (e) Parental BaF/6-1 cells or the CagADN transfectant cells were cultured in the absence or presence of 625 mm HU for 6 h. Total RNA was extracted from cells using TRIzol reagent (Invitrogen) and was reverse transcribed using oligo dT primer and reverse transcriptase (Super Script II Reverse Transcriptase; Invitrogen). PCR reactions were performed with ABI PRISM 7000 Sequence Detection System (PE Biosystems) using QuantiTect SYBR Green PCR Kit (QIAGEN). PCR amplification protocol consists of: 501C for 2 min and 951C for 10 min, followed by 40 cycles of 941C for 30 s, 561C for 30 s, and 721C for 30 s. The data were normalized by the mRNA expression levels of b-actin. Primers used were: p53 forward, 5 0 -GAGGCCGGCTCTGAGTATACC-3 0 ; p53 reverse, 5
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Effects of H. pylori CagA on B cells S Umehara et al restricted to lymphoid cells. Such a lymphoid-specific CagA activity may be advantageous to H. pylori, because it should hamper rapid expansion of H. pylori-specific immune cells. We have also provided evidence that CagA counteracts B-cell apoptosis induced by hydroxyurea through inhibiting p53 accumulation. Escape from apoptosis is an essential prerequisite for malignant transformation of cells. H. pylori infection induces immune reaction and sustains an active proliferating B-cell population, from which a small but significant amount of genetically abnormal cells appear. Development of MALT lymphoma should involve multiple bacterial and host factors. Among these, inhibition of p53 by the injected CagA may contribute to the accumulation of genetic mutations in such abnormal B cells by allowing inappropriate cell survival. Cytogenetic studies have shown that t(11;18)(q21;q21) translocation occurs in 30-40% of gastric MALT lymphomas (Auer et al., 1997; Ott et al., 1997) and that this genetic rearrangement generates a API2-MALT1 fusion product (Dierlamm et al., 1999; Baens et al., 2000) . Since the fusion protein has been suggested to possess anti-apoptotic activity (Du and Isaacson, 2002) , acquisition of such a genetic rearrangement would confer the lymphoma cells CagAindependence. Hence, cagA-positive H. pylori may be more associated with the initial phase of gastric MALT lymphoma development and might not be necessary for sustained lymphoma cell proliferation.
